U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H19ClN4O5
Molecular Weight 454.863
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TIVOZANIB

SMILES

COC1=CC2=C(C=C1OC)C(OC3=CC(Cl)=C(NC(=O)NC4=NOC(C)=C4)C=C3)=CC=N2

InChI

InChIKey=SPMVMDHWKHCIDT-UHFFFAOYSA-N
InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
TIVOZANIB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
KIL8951
Code English
KIL-8951
Code English
UREA, N-(2-CHLORO-4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N'-(5-METHYL-3-ISOXAZOLYL)-
Systematic Name English
N-(2-CHLORO-4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(5-METHYLISOXAZOL-3-YL)UREA
Systematic Name English
Tivozanib [WHO-DD]
Common Name English
tivozanib [INN]
Common Name English
KRN-951
Code English
TIVOZANIB [USAN]
Common Name English
AV-951
Code English
Classification Tree Code System Code
WHO-ATC L01XE34
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
NCI_THESAURUS C93259
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
Code System Code Type Description
RXCUI
2534233
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
CAS
475108-18-0
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
SMS_ID
100000134791
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
DRUG BANK
DB11800
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
DRUG CENTRAL
5258
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
EPA CompTox
DTXSID20963865
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
PUBCHEM
9911830
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
USAN
ZZ-29A
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
NCI_THESAURUS
C85444
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
INN
9203
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
ChEMBL
CHEMBL1289494
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
EVMPD
SUB64411
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
WIKIPEDIA
TIVOZANIB
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
DAILYMED
172030934T
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
FDA UNII
172030934T
Created by admin on Sat Dec 16 15:46:53 UTC 2023 , Edited by admin on Sat Dec 16 15:46:53 UTC 2023
PRIMARY
ACTIVE MOIETY
Structure of TIVOZANIB
SALT/SOLVATE (PARENT)
Structure of TIVOZANIB HYDROCHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966